John Lewicki
Chief Tech/Sci/R&D Officer bij MEREO BIOPHARMA GROUP PLC
Vermogen: 2 402 $ op 31-03-2024
Actieve functies van John Lewicki
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MEREO BIOPHARMA GROUP PLC | Chief Tech/Sci/R&D Officer | 01-07-2020 | - |
Loopbaan van John Lewicki
Eerdere bekende functies van John Lewicki
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ONCOMED PHARMACEUTICALS INC | Director/Board Member | 19-03-2018 | 23-04-2019 |
Chief Executive Officer | 19-03-2018 | 23-04-2019 | |
Chief Tech/Sci/R&D Officer | 01-01-2004 | 21-02-2018 | |
President | 21-02-2018 | 23-04-2019 | |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Chief Tech/Sci/R&D Officer | - | - |
Corporate Officer/Principal | 01-01-1983 | 01-01-2000 |
Opleiding van John Lewicki
University of California San Diego | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Verenigd Koninkrijk | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MEREO BIOPHARMA GROUP PLC | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
- Beurs
- Insiders
- John Lewicki
- Ervaring